Xulane 150-35 MCG/day patch 3S
Ended Awarded
- Contract number
- SPE2DR26F6BU9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,798
Award facts
- Contract value 100% obligated
- $8,798.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,798.39 delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY transdermal patches (3-pack) on October 28, 2025, with completion targeted for October 29, 2025. This competitive award utilizes a firm fixed-price delivery order model and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal healthcare systems, including military and veteran medical programs.
This delivery order falls under AmerisourceBergen's $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The award demonstrates the company's continued capacity to fulfill federal medical supply requirements through open competition and reflects DLA's reliance on established prime vendors for pharmaceutical procurement across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F6BU9?
SPE2DR26F6BU9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26F6BU9 worth?
The government has obligated $8,798 on SPE2DR26F6BU9.
Is contract SPE2DR26F6BU9 an order under another contract?
Yes. SPE2DR26F6BU9 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6BU9 competed?
The extent of competition for SPE2DR26F6BU9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award